Syndrome de Li-Fraumeni : Questions médicales fréquentes
Nom anglais: Li-Fraumeni Syndrome
Descriptor UI:D016864
Tree Number:C18.452.284.520
Termes MeSH sélectionnés :
Pilot Projects
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Syndrome de Li-Fraumeni : Questions médicales les plus fréquentes",
"headline": "Syndrome de Li-Fraumeni : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Syndrome de Li-Fraumeni : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-23",
"dateModified": "2025-04-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Syndrome de Li-Fraumeni"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Troubles dus à un défaut de réparation de l'ADN",
"url": "https://questionsmedicales.fr/mesh/D049914",
"about": {
"@type": "MedicalCondition",
"name": "Troubles dus à un défaut de réparation de l'ADN",
"code": {
"@type": "MedicalCode",
"code": "D049914",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C18.452.284"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Li-Fraumeni",
"alternateName": "Li-Fraumeni Syndrome",
"code": {
"@type": "MedicalCode",
"code": "D016864",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Payal P Khincha",
"url": "https://questionsmedicales.fr/author/Payal%20P%20Khincha",
"affiliation": {
"@type": "Organization",
"name": "Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland."
}
},
{
"@type": "Person",
"name": "David Malkin",
"url": "https://questionsmedicales.fr/author/David%20Malkin",
"affiliation": {
"@type": "Organization",
"name": "Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, and Department of Pediatrics, University of Toronto, Toronto, Ontario."
}
},
{
"@type": "Person",
"name": "Sharon A Savage",
"url": "https://questionsmedicales.fr/author/Sharon%20A%20Savage",
"affiliation": {
"@type": "Organization",
"name": "Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland."
}
},
{
"@type": "Person",
"name": "Allison Werner-Lin",
"url": "https://questionsmedicales.fr/author/Allison%20Werner-Lin",
"affiliation": {
"@type": "Organization",
"name": "School of Social Policy and Practice, University of Pennsylvania, Philadelphia, PA."
}
},
{
"@type": "Person",
"name": "Maria Isabel Achatz",
"url": "https://questionsmedicales.fr/author/Maria%20Isabel%20Achatz",
"affiliation": {
"@type": "Organization",
"name": "Centro de Oncologia, Hospital Sirio-Libanes, Rua Dona Adma Jafet, 115 - Bela Vista, São Paulo, Brazil."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "SARS-CoV-2 rapid antigen screening of asymptomatic employees: a pilot project.",
"datePublished": "2022-09-12",
"url": "https://questionsmedicales.fr/article/36097245",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.17269/s41997-022-00691-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Health Disparities Investigator Development through a Team-Science Pilot Projects Program.",
"datePublished": "2023-03-30",
"url": "https://questionsmedicales.fr/article/37047951",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph20075336"
}
},
{
"@type": "ScholarlyArticle",
"name": "Global pen pal education intervention among student pharmacists: A pilot project.",
"datePublished": "2022-09-22",
"url": "https://questionsmedicales.fr/article/36153244",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cptl.2022.09.020"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Disposable Diaper Collection Project in Langa, Cape Town, South Africa: A Pilot Study.",
"datePublished": "2024-09-27",
"url": "https://questionsmedicales.fr/article/39457265",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph21101292"
}
},
{
"@type": "ScholarlyArticle",
"name": "Changing the Playing Field: A Prehospital Blood Product Pilot Project in Rural North Georgia.",
"datePublished": "2023-02-16",
"url": "https://questionsmedicales.fr/article/36798046",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/00031348231157833"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies métaboliques et nutritionnelles",
"item": "https://questionsmedicales.fr/mesh/D009750"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies métaboliques",
"item": "https://questionsmedicales.fr/mesh/D008659"
},
{
"@type": "ListItem",
"position": 4,
"name": "Troubles dus à un défaut de réparation de l'ADN",
"item": "https://questionsmedicales.fr/mesh/D049914"
},
{
"@type": "ListItem",
"position": 5,
"name": "Syndrome de Li-Fraumeni",
"item": "https://questionsmedicales.fr/mesh/D016864"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Syndrome de Li-Fraumeni - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Syndrome de Li-Fraumeni",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-01",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Syndrome de Li-Fraumeni",
"description": "Comment est diagnostiqué le syndrome de Li-Fraumeni ?\nQuels tests génétiques sont utilisés ?\nQuels critères cliniques sont utilisés pour le diagnostic ?\nLe diagnostic peut-il être posé à tout âge ?\nLes tests de dépistage sont-ils recommandés ?",
"url": "https://questionsmedicales.fr/mesh/D016864?mesh_terms=Pilot+Projects&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Syndrome de Li-Fraumeni",
"description": "Quels sont les symptômes du syndrome de Li-Fraumeni ?\nLes symptômes apparaissent-ils à un âge précoce ?\nY a-t-il des signes spécifiques à surveiller ?\nLes symptômes sont-ils toujours liés à des cancers ?\nLes symptômes peuvent-ils varier d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D016864?mesh_terms=Pilot+Projects&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Syndrome de Li-Fraumeni",
"description": "Comment prévenir le syndrome de Li-Fraumeni ?\nLes personnes à risque doivent-elles se faire dépister ?\nY a-t-il des recommandations pour les familles touchées ?\nLes habitudes de vie peuvent-elles influencer le risque ?\nLes tests génétiques sont-ils recommandés pour tous ?",
"url": "https://questionsmedicales.fr/mesh/D016864?mesh_terms=Pilot+Projects&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Syndrome de Li-Fraumeni",
"description": "Quels traitements sont disponibles pour ce syndrome ?\nLa prévention des cancers est-elle possible ?\nLes traitements sont-ils différents selon le cancer ?\nY a-t-il des traitements expérimentaux disponibles ?\nLe suivi post-traitement est-il important ?",
"url": "https://questionsmedicales.fr/mesh/D016864?mesh_terms=Pilot+Projects&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Syndrome de Li-Fraumeni",
"description": "Quelles complications peuvent survenir avec ce syndrome ?\nLes complications sont-elles prévisibles ?\nComment gérer les complications psychologiques ?\nLes complications peuvent-elles affecter la qualité de vie ?\nY a-t-il des complications spécifiques aux traitements ?",
"url": "https://questionsmedicales.fr/mesh/D016864?mesh_terms=Pilot+Projects&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Syndrome de Li-Fraumeni",
"description": "Quels sont les principaux facteurs de risque ?\nLe mode de vie influence-t-il le risque ?\nLes femmes sont-elles plus à risque ?\nL'âge joue-t-il un rôle dans le risque ?\nLes facteurs environnementaux sont-ils impliqués ?",
"url": "https://questionsmedicales.fr/mesh/D016864?mesh_terms=Pilot+Projects&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment est diagnostiqué le syndrome de Li-Fraumeni ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique familial et des tests génétiques pour identifier des mutations."
}
},
{
"@type": "Question",
"name": "Quels tests génétiques sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests ciblent principalement les gènes TP53 et d'autres gènes associés au cancer."
}
},
{
"@type": "Question",
"name": "Quels critères cliniques sont utilisés pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent des antécédents familiaux de cancers précoces et multiples."
}
},
{
"@type": "Question",
"name": "Le diagnostic peut-il être posé à tout âge ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diagnostic peut être établi à tout âge, souvent après l'apparition de cancers."
}
},
{
"@type": "Question",
"name": "Les tests de dépistage sont-ils recommandés ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un dépistage régulier est conseillé pour détecter précocement les cancers."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes du syndrome de Li-Fraumeni ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient selon le type de cancer, incluant des douleurs, des masses et des changements de poids."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils à un âge précoce ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les cancers associés apparaissent souvent chez les jeunes adultes ou même les enfants."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes spécifiques à surveiller ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveillez les douleurs persistantes, les changements cutanés et les anomalies mammaires."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours liés à des cancers ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas toujours, mais tout symptôme persistant doit être évalué par un professionnel."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'expression des symptômes peut varier en fonction des cancers développés."
}
},
{
"@type": "Question",
"name": "Comment prévenir le syndrome de Li-Fraumeni ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de prévention, mais un dépistage régulier peut aider à détecter les cancers tôt."
}
},
{
"@type": "Question",
"name": "Les personnes à risque doivent-elles se faire dépister ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes à risque élevé doivent suivre un programme de dépistage régulier."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations pour les familles touchées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les familles doivent consulter des conseillers en génétique pour des recommandations personnalisées."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie peuvent-elles influencer le risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter un mode de vie sain peut réduire le risque de certains cancers, mais pas tous."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils recommandés pour tous ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils sont recommandés principalement pour les personnes ayant des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour ce syndrome ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, la chimiothérapie et la radiothérapie selon le cancer."
}
},
{
"@type": "Question",
"name": "La prévention des cancers est-elle possible ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance régulière et des interventions précoces peuvent aider à prévenir certains cancers."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils différents selon le cancer ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque type de cancer peut nécessiter un traitement spécifique adapté."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux disponibles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des essais cliniques peuvent offrir des options de traitement innovantes pour les patients."
}
},
{
"@type": "Question",
"name": "Le suivi post-traitement est-il important ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier est crucial pour détecter toute récidive ou nouveaux cancers."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec ce syndrome ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des cancers multiples, des effets secondaires des traitements et des problèmes psychologiques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être anticipées, mais d'autres peuvent survenir de manière inattendue."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications psychologiques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un soutien psychologique et des groupes de soutien peuvent aider à gérer l'anxiété et la dépression."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications liées aux traitements et aux cancers peuvent altérer la qualité de vie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications spécifiques aux traitements ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent entraîner des effets secondaires comme la fatigue, la nausée et l'immunosuppression."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux de cancers et les mutations génétiques, notamment TP53, sont des facteurs clés."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs comme le tabagisme et l'alimentation peuvent influencer le risque de cancer."
}
},
{
"@type": "Question",
"name": "Les femmes sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, le syndrome affecte également les hommes, bien que certains cancers soient plus fréquents chez les femmes."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de développer des cancers augmente avec l'âge, surtout après 30 ans."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux sont-ils impliqués ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs environnementaux peuvent contribuer au risque, mais le syndrome est principalement génétique."
}
}
]
}
]
}
Rapid antigen screening can be effective in identifying infectious individuals in occupational settings to reduce transmission and outbreaks. We report results from a pilot project at the Greater Toro...
An employee screening program was piloted between March 8 and May 28, 2021, to implement rapid antigen testing for asymptomatic employees. Recruitment targeted enrolment of 400 employees and yielded p...
A total of 5117 tests were performed on 717 individuals over 12 weeks; 5091 tests were negative (99.5%), and 22 individuals tested positive (3.1% positivity rate). One hundred twenty-four (17%) comple...
This pilot program identified 22 (3.1%) potentially infectious employees. Onsite testing was feasible and highly accepted by this group of employees who completed the survey. Education resulted in rea...
Profound health disparities are widespread among Native Hawaiians, other Pacific Islanders, and Filipinos in Hawai'i. Efforts to reduce and eliminate health disparities are limited by a shortage of in...
Global health, a practice that prioritizes improving health and achieving health equity for all people worldwide, is a priority for pharmacists, schools, and pharmacy colleges. Several initiatives aim...
This mixed-method study included assigned engagement within a required or elective didactic course, followed by a post-experience survey. Each student was pre-assigned a pen pal from a cohort of pharm...
In total, 184 students completed the learning experience, and across both sites, 63 students completed the post-experience survey. The students' impressions of the PPP varied by site, yet most partici...
In developing countries, there is currently no established waste management plan that includes resource recovery from used disposable diapers (DDs) apart from incineration and landfilling. In low-inco...
In Georgia, the paramedic's scope of practice prohibited the initiation of blood products. Due to the rural landscape in Georgia, one region's Regional Trauma Advisory Committee (RTAC) advocated expan...
Approval was obtained from the state medical directors and the Office of EMS and Trauma. The project team addressed product selection, equipment, prehospital service selection, education, policies and...
The pilot project began in spring of 2020, and as of January 2023, there have been 100 field initiations and no adverse effects, demonstrating the safety of paramedics to initiate blood products in th...
Future physicians are insufficiently prepared for the topic of transgender identity during their studies. Relevant courses during undergraduate medical education are heterogeneous and not widely estab...
During summer semester 2021 (SS21), the knowledge level on transgender identity of 134 medical students in their fifth clinical semester was evaluated (phase 1). In addition, knowledge gain on gender ...
The students in SS21 did not feel sufficiently educated in the topic of transgender identity through their studies, but rated the relevance of the topic for their later profession as high. Learning ga...
One 90-minutes seminar led to a significant learning gain regarding the topic of transgender identity. Community-supported teaching is a promising way to impart knowledge in a qualified manner: Medica...
To trial methods for a future longitudinal study to: a) assess how the redevelopment of a large social housing estate affects the health of tenants; and b) act on health needs identified throughout th...
Participants recruited from the tenant population completed (online or face-to-face) a health questionnaire covering self-reported health status and behaviours, housing conditions, sense of community,...
A total of 24 tenants were recruited for the pilot study against a target sample size of 50. The health questionnaire and referral process worked as expected, with no issues reported....
This pilot study successfully trialled methods for: a) assessing tenants' health; and b) referring those identified as being likely to have unmet health service needs to a community-based link worker,...
We developed a paediatric haemodialysis trigger tool (pHTT) for application per haemodialysis (HD) session in children receiving intermittent in-centre HD and systematically monitored adverse events....
Single-centre quality improvement study performed over two 8-week cycles. Data collected prospectively using a 'per-dialysis session' pHTT tool including 54 triggers across six domains, adapted from a...
There were 241 triggers over 182 dialysis sessions, with 139 triggers in 91 HD sessions for 15 children, age range 28-205 months, over an 8-week period (first cycle) and 102 triggers in 91 HD sessions...
This pilot study demonstrates potential benefits of a bedside tool to monitor adverse events during haemodialysis in children. Thus, following interventions informed by the pHTT, the harm rate per ses...
American Indian Alaska Native (AIAN) youth have disproportionately higher rates of commercial tobacco product use compared to other racial and ethnic groups in the U.S. These rates underscore a need f...
The "Virtual Semester for Medical Research Aachen" (vSEMERA) is an international, interdisciplinary, virtual education program developed for health profession students. The first edition (2021) was ho...
vSEMERA was built on a virtual learning platform, the "vSEMERA-Campus", designed to foster students' learning process and social interactions. Maximum flexibility was offered through synchronous and a...
The program received a rating of 4.38 out of 5 stars. While it met most expectations (4.29 out of 5), participants were unable to attend as many courses as intended (2.81 out of 5), mainly due to sche...
vSEMERA represents a promising example of an online international learning and exchange program using pedagogical and technological elements of virtual collaboration and teaching. In addition to advan...